RYTM Rhythm Pharmaceuticals, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
23:38
Aug 19
Aug 19
The author lists speculative biotech catalysts and best ideas by therapeutic area.
The author lists speculative biotech catalysts and best ideas by therapeutic area as research/watchlist content, not explicit current positions or forward calls.
23:36
Aug 19
Aug 19
Top biotech picks across various therapeutic areas
Author lists these biotech names as their best ideas across various therapeutic areas with the sector near all-time highs.
MED
12:58
Aug 17
Aug 17
Reports largest aggregate Q2 fund holdings
"Reports largest aggregate Q2 2026 holdings across 95 specialist funds based on 13F filings, no directional view."
MED
12:31
Aug 17
Aug 17
Notes large aggregate Q2 fund holdings
Notes the stock is among the largest aggregate Q2 holdings across 93 funds based on 13F filings.
MED
00:07
Jul 27
Jul 27
The author is highly confident in biotech timing, recommending XBI as a bottom and naming RVMD.
The author is highly confident in biotech timing, recommending XBI as a bottom and naming RVMD, ABVX, TENX, and NKTR as high-conviction longs with specific catalysts and price targets.
22:58
May 17
May 17
"Checkpoint Capital increased positions in ARGX, CYTK, RYTM in Q1 2026.
"Checkpoint Capital increased positions in ARGX, CYTK, RYTM in Q1 2026. Fund disclosure, no speaker thesis."
HIGH
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions.
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
About RYTM Analyst Coverage
Buzzberg tracks RYTM (Rhythm Pharmaceuticals, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 7 total trade ideas tracked. Latest voices: seedy19tron.